NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 07 01:43PM ET
19.79
Dollar change
-0.27
Percentage change
-1.35
%
CategoryTarget Date / Multi-Asset - Other Asset TypeMulti-Asset - Tactical / Active TagsGlobal Return% 1Y7.74% Total Holdings101 Perf Week-0.01%
SponsorEvoke Advisors ETF Type Tagsequity Return% 3Y3.37% AUM517.56M Perf Month0.20%
Fund Family Bond Type Tagstreasuries Return% 5Y1.49% NAV/sh Perf Quarter1.02%
Index- Average Maturity Tagscommodity Return% 10Y 52W High20.79 -4.81% Perf Half Y5.91%
Index Weighting Commodity Type Tagsinflation Return% SI 52W Low17.91 10.50% Perf YTD5.91%
Active/Passive Quant Type Tags- Flows% 1M-1.14% Volatility0.66% 0.64% Perf Year3.95%
Dividend TTM0.54 (2.71%) ESG Type Tags- Flows% 3M-5.89% ATR (14)0.16 Perf 3Y0.66%
Dividend Ex-DateJun 27, 2025 Dividend Type Sector/Theme Flows% YTD-8.75% RSI (14)50.01 Perf 5Y-6.05%
Dividend Gr. 3/5Y-2.56% 58.49% Structure Type Region Flows% 1Y Beta0.70 Perf 10Y-
Expense0.50% Growth/Value SMA20-0.33% Flows% 3Y Rel Volume0.24 Prev Close20.06
Inverse/Leveraged Market Cap SMA500.96% Flows% 5Y Avg Volume52.29K Price19.79
IPODec 13, 2019 Option/ShortYes / Yes SMA2001.27% Trades Volume8,525 Change-1.35%
RPAR Risk Parity ETF seeks to generate positive returns during periods of economic growth, preserve capital during periods of economic contraction, and preserve real rates of return during periods of heightened inflation. The fund is an actively-managed exchange-traded fund that seeks to achieve its investment objective primarily by investing across a variety of asset classes, including exposure to global equity securities, U.S. Treasury securities, and commodities. It's investment adviser seeks to invest the fund's assets to achieve exposures similar to those of the Advanced Research Risk Parity Index.